Clinical Trials Browser

Phase NA × Recruiting × Genetic Testing × Clear all

NCT05694559 2026-02-19

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Phase NA Recruiting

1,000 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT06569316 2026-01-29

Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)

Phase NA Recruiting

300 enrolled

Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT04494945 2026-01-23

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Phase NA Recruiting

27,500 enrolled

BreastGastrointestinalGynecologic

Carcinoma, Intraductal, Noninfiltrating, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplastic Syndromes, Hereditary, Hereditary Breast and Ovarian Cancer Syndrome

NCT06574620 2026-01-16

ACCELERATE

Phase NA Recruiting

200 enrolled

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06630104 2026-01-08

Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

Phase NA Recruiting

82 enrolled

LymphoidPlasma cell

Lymphoproliferative Disorders, Multiple Myeloma

NCT04763980 2025-12-31

Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer

Phase NA Recruiting

72 enrolled

Genitourinary

Prostatic Neoplasms

NCT05649072 2025-11-19

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

1,000 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT04475640 2025-10-30

Cancer Genetic Testing in Ethnic Populations

Phase NA Recruiting

1,800 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasms, Unknown Primary

NCT06363162 2024-04-12

Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery

Phase NA Recruiting

200 enrolled

CNS

Glioma